We are live on ! Find out more
NGNE icon

Neurogene
NGNE

85 hedge funds and large institutions have $187M invested in Neurogene in 2021 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 26 increasing their positions, 28 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

230% more call options, than puts

Call options by funds: $287K | Put options by funds: $87K

50% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 8

4% more funds holding

Funds holding: 82 → 85 (+3)

0.14% less ownership

Funds ownership: 3.18% → 3.05% (-0.14%)

7% less repeat investments, than reductions

Existing positions increased: 26 | Existing positions reduced: 28

25% less capital invested

Capital invested by funds: $249M → $187M (-$61.5M)

Holders
85
Holders Change
+3
Holders Change %
+3.66%
% of All Funds
1.49%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
12
Increased
26
Reduced
28
Closed
8
Calls
$287K
Puts
$87K
Net Calls
+$200K
Net Calls Change
+$1.46M

Top Buyers

Rank Fund Capital Flow
1
CS
Candriam SCA
Luxembourg
+$2.65M
2
Renaissance Technologies
Renaissance Technologies
New York
+$1.38M
3
Millennium Management
Millennium Management
New York
+$938K
4
Point72 Asset Management
Point72 Asset Management
Connecticut
+$895K
5
Two Sigma Advisers
Two Sigma Advisers
New York
+$880K

Top Sellers

Rank Fund Capital Flow
1
EC
EcoR1 Capital
California
-$11.5M
2
State Street
State Street
Massachusetts
-$4.78M
3
RG
Redmile Group
California
-$3.15M
4
OM
Opaleye Management
Massachusetts
-$834K
5
Goldman Sachs
Goldman Sachs
New York
-$697K
Name Holding Trade Value Shares
Change 		Change in
Stake
Osaic Holdings
76
Osaic Holdings
Arizona
$11K +$3.83K +25 +50%
PHK
77
Point72 Hong Kong
Hong Kong
$10K -$1.99K -13 -16%
TC
78
Truvestments Capital
Florida
$10K – – –
PCM
79
Penserra Capital Management
California
$7K +$153 +1 +2%
S
80
SignatureFD
Georgia
$4K +$3.67K +24 New
Daiwa Securities Group
81
Daiwa Securities Group
Japan
$1K – – –
US Bancorp
82
US Bancorp
Minnesota
$1K +$1.23K +8 New
Rafferty Asset Management
83
Rafferty Asset Management
New York
– -$335K -1,813 Closed
Cerity Partners
84
Cerity Partners
New York
– -$286K -1,550 Closed
Qube Research & Technologies (QRT)
85
Qube Research & Technologies (QRT)
United Kingdom
– -$151K -819 Closed
DekaBank Deutsche Girozentrale
86
DekaBank Deutsche Girozentrale
Germany
– -$129K -700 Closed
CW
87
CreativeOne Wealth
Kansas
– -$97K -525 Closed
SOW
88
State of Wyoming
Wyoming
– -$15K -79 Closed
EVM
89
Eaton Vance Management
Massachusetts
– -$2K -11 Closed
GWM
90
Geneos Wealth Management
Colorado
– -$2K -11 Closed
EI
91
Ellevest Inc
New York
– +$153 +1 New
LC
92
Lindbrook Capital
California
– +$306 +2 New
PA
93
Parallel Advisors
California
– +$459 +3 New
1 2 3
4

NGNE Hedge Fund Activity: Q3 2021 in Review

85 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Neurogene (NGNE) for Q3 2021, worth a combined $187M — down 25% from $249M a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new NGNE positions and 8 closed out — a net gain of 4 holders — while 26 added to existing stakes and 28 trimmed.

The largest buyer was Candriam SCA, adding an estimated $2.65M. The largest seller was EcoR1 Capital, cutting an estimated $11.5M.

  • 85 institutional investors held Neurogene (NGNE) as of Q3 2021, up from 82 in Q2 2021.
  • Funds reported $187M of Neurogene stock for Q3 2021, down 25% quarter-over-quarter.
  • 12 funds opened new Neurogene positions in Q3 2021 and 8 closed out, a net change of +4 holders.
  • The largest Neurogene buyer in Q3 2021 was Candriam SCA, an estimated $2.65M added.
  • The largest Neurogene seller in Q3 2021 was EcoR1 Capital, an estimated $11.5M sold.

Based on aggregated 13F filings for Q3 2021.